Trastuzumab emtansine

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T36647-5mg	5 mg		-		7 - 10 business days*		1,294.00€
TGM-T36647-10mg	10 mg		-		7 - 10 business days*		2,110.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate... more

Close menu

Product information "Trastuzumab emtansine"

Description: Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that combines the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of DM1, a microtubule-inhibitory derivative of maytansine, and is utilized in the investigation of advanced breast cancer[1][2]. Target: Antibody-Drug Conjugates (ADCs), Others. Smiles: [Trastuzumab emtansine]. References: Verma S, et, al. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012 Nov 8,367(19):1783-91.

Supplier:	TargetMol
Supplier-Nr:	T36647

Properties

Application:	Targets receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] (ERBB2, HER2, CD340)
Conjugate:	No

Database Information

CAS :	1018448-65-1\| Matching products
KEGG ID :	K05083 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Trastuzumab emtansine"

Write a review